.jpg)
Director of Medical Affairs
Eiger Pharmaceuticals
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Amin Boroujerdi received his Ph.D. in Pharmacology and Toxicology from the University of California Irvine. His thesis focused on identifying and understanding novel mechanisms of neuropathic pain in which he published multiple studies on. His interest in pain and inflammation result in him accepting a post-doctoral position at the world famous Scripps Institute in the department of Molecular & Experimental Medicine where he focused on inflammation in neurovascular diseases. He had received multiple grants from Multiple Sclerosis Society and American Heart Association.
Dr. Boroujerdi then joined Global Medical Affairs for Allergan Pharmaceutical focused on symptoms/conditions related to neurological disorders. He became a medical director in urology and spasticity/movement disorder where he spent his time providing medical education to health care professionals focused in this field. During his time at Allergan/AbbVie as a medical director his interest in digital innovation lead him to be involved as one of the first to pioneer and develop a virtual reality training project to optimize injection of onabotulinumtoxinA for the treatment of spasticity. He received the 2020 AbbVie R&D Presidential award for his role in this project. Currently Dr. Boroujerdi is a Director of Medical Affairs at Eiger Biopharmaceuticals focused on treating orphan diseases of Progeria and hepatitis D.
